ENTRY       D08503                      Drug
NAME        Toceranib (USAN)
FORMULA     C22H25FN4O2
EXACT_MASS  396.1962
MOL_WEIGHT  396.4579
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
REMARK      Chemical structure group: DG01363
EFFICACY    Antineoplastic (veterinary), Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor
COMMENT     Treatment of mast cell tumors in dogs
TARGET      KIT (CD117) [HSA:3815] [KO:K05091]
            VEGFR2 (KDR) [HSA:3791] [KO:K05098]
            PDGFR [HSA:5156 5159] [KO:K04363 K05089]
  PATHWAY   hsa04010(3791+3815+5156+5159)  MAPK signaling pathway
            hsa04151(3791+3815+5156+5159)  PI3K-Akt signaling pathway
            hsa04370(3791)  VEGF signaling pathway
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG01363  Toceranib
                 D08503  Toceranib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               PDGFR family
                PDGFR
                 D08503  Toceranib (USAN)
                KIT (CD117)
                 D08503  Toceranib (USAN)
               VEGFR family
                VEGFR2 (KDR)
                 D08503  Toceranib (USAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG01363  Toceranib
DBLINKS     CAS: 356068-94-5
            PubChem: 96025188
            PDB-CCD: BWC
            LigandBox: D08503
ATOM        29
            1   C8x C    17.1500   -5.8800
            2   C8x C    15.9600   -6.5800
            3   C8y C    15.9600   -7.9800
            4   C8x C    17.1500   -8.6800
            5   C8y C    18.3400   -7.9800
            6   C8y C    18.3400   -6.5800
            7   C2y C    19.7400   -8.4000
            8   C5x C    20.5100   -7.2800
            9   N1x N    19.7400   -6.1600
            10  X   F    14.7700   -8.6800
            11  O5x O    21.9100   -7.2800
            12  C2b C    19.7400   -9.8000
            13  C8y C    20.9300  -10.5000
            14  C8y C    20.9300  -11.9000
            15  C8y C    22.2600  -12.3200
            16  C8y C    23.0300  -11.2000
            17  N4x N    22.2600  -10.0800
            18  C1a C    19.7400  -12.7400
            19  C1a C    24.5000  -11.2000
            20  C5a C    22.2600  -13.7900
            21  O5a O    21.0700  -14.4900
            22  N1b N    23.5200  -14.4900
            23  C1b C    24.7100  -13.7900
            24  C1b C    25.9000  -14.4900
            25  N1y N    27.0900  -13.7900
            26  C1x C    28.4247  -14.2127
            27  C1x C    29.2391  -13.0740
            28  C1x C    28.4078  -11.9475
            29  C1x C    27.0796  -12.3900
BOND        32
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    6   9 1
            11    3  10 1
            12    8  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17   15  16 2
            18   16  17 1
            19   13  17 1
            20   14  18 1
            21   16  19 1
            22   15  20 1
            23   20  21 2
            24   20  22 1
            25   22  23 1
            26   23  24 1
            27   24  25 1
            28   25  26 1
            29   26  27 1
            30   27  28 1
            31   28  29 1
            32   25  29 1
///
